INTERVIEW: 23andMe uses people power to push personalized medicine into new fields
This article was originally published in Clinica
Executive Summary
23andMe’s announcement earlier this month that it had teamed up with pharmaceutical firm Pfizer in inflammatory bowel disease (IBD) could pave the way for the expansion of personalized medicine into a new area.